Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Sylvain Gauthier"'
Publikováno v:
NICE 2023-Neuro-Inspired Computational Elements Workshop
NICE 2023-Neuro-Inspired Computational Elements Workshop, Apr 2023, San Antonio, TX, United States. ⟨10.1145/3584954.3584999⟩
Proceedings of the 2023 Annual Neuro-Inspired Computational Elements Conference, NICE 2023, 100-107
STARTPAGE=100;ENDPAGE=107;TITLE=Proceedings of the 2023 Annual Neuro-Inspired Computational Elements Conference, NICE 2023
NICE 2023-Neuro-Inspired Computational Elements Workshop, Apr 2023, San Antonio, TX, United States. ⟨10.1145/3584954.3584999⟩
Proceedings of the 2023 Annual Neuro-Inspired Computational Elements Conference, NICE 2023, 100-107
STARTPAGE=100;ENDPAGE=107;TITLE=Proceedings of the 2023 Annual Neuro-Inspired Computational Elements Conference, NICE 2023
International audience; Mobile robot navigation tasks can be applied in various domains, such as in space, underwater, and transportation industries, among others. In navigation, robots analyze their environment from sensors and navigate safely up to
Publikováno v:
The Journal of Steroid Biochemistry and Molecular Biology. 132:93-104
Background While the androgens of testicular origin (representing about 50% of total androgens in men over 50 years) can be completely eliminated by surgical or medical castration with GnRH (gonadotropin-releasing hormone) agonists or antagonists, th
Autor:
Agnès Coquet, Jean-Yves Sancéau, Fernand Labrie, Denis Larouche, Patrick Bélanger, Alain Bélanger, Brigitte Caron, Sylvain Gauthier
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 50:197-206
Acolbifene (EM-652·HCl, SCH 57068·HCl), a highly potent and orally active selective estrogen receptor modulator (SERM), is at late stage clinical development for the treatment of estrogen-sensitive breast cancer. Acolbifene-7-glucuronide 1 (major)
Autor:
Alexandre Favre, Yves Merand, Jacques Simard, Carl Ouellet, Yves L. Dory, Céline Martel, Fernand Labrie, Julie Cloutier, Annette Schwerdtfeger, Sylvain Gauthier, Josée Mailhot
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry. 20:165-177
EM-652 (acolbifene) analogs have been synthesized as selective estrogen receptor modulators. Substitution on the nitrogen atom of these 2H-1-benzopyran derivatives has been studied for its influence on antiestrogenic activity. Binding to the rat estr
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 47:741-752
EM-800 (SCH 57050) and EM-652·HCl (SCH 57068·HCl, acolbifene) are orally active pure selective estrogen receptor modulators. The corresponding 14C2-radiolabelled compounds 1 and 2 were synthesized for metabolic studies with uniform labelling of two
Publikováno v:
Current Medicinal Chemistry. 7:211-247
Prostate cancer, acne, seborrhea, hirsutism, and androgenic alopecia are well recognized to depend upon an excess or increased sensitivity to androgens or to be at least sensitive to androgens. It thus seems logical to use antiandrogens as therapeuti
Publikováno v:
Tetrahedron. 56:703-709
A new, highly stereoselective synthesis of ( E )-droloxifene is reported. Deprotection of 3,4′-dimethoxybenzophenone and selective pivaloylation of the 3′-phenolic position gave 4-hydroxy-3′-(trimethylacetoxy)benzophenone. A McMurry reaction be
Autor:
Yves Merand, Van Luu-The, Claude Labrie, Shankar M. Singh, Alain Bélanger, Gilles Tremblay, Céline Martel, Fernand Labrie, Shouqi Luo, Sylvain Gauthier, Gilles Charpenet, Vincent Giguère, Ronald Charbonneau, Lionel Cusan, Agnès Coquet, Raymonde Veilleux, Virgile Richard, Jacques Simard, Bernard Candas, André J. Tremblay, Marc Fournier
Publikováno v:
The Journal of Steroid Biochemistry and Molecular Biology. 69:51-84
Breast cancer is the most frequent cancer in women while it is the second cause of cancer death. Estrogens are well recognized to play the predominant role in breast cancer development and growth and much efforts have been devoted to the blockade of
Autor:
Shouqi Luo, Claude Labrie, Alain Bélanger, Fernand Labrie, Antigone Sourla, Yves Merand, Sylvain Gauthier
Publikováno v:
Endocrinology. 139:2645-2656
Treatment with the antiestrogen EM-800, at the daily oral dose of 3μ g, 10 μg, 30 μg, or 100 μg for 24 weeks, caused a marked inhibition of uterine and vaginal weight in both intact and ovariectomized mice. Maximal 64% and 41% inhibitions of uter
Autor:
Céline Martel, Fernand Labrie, Yves Merand, Sylvain Gauthier, Gilles Leblanc, Alain St. Pierre, Louis Provencher, Xun Li
Publikováno v:
The Journal of Steroid Biochemistry and Molecular Biology. 64:199-205
Tamoxifen (TAM), the only antiestrogen currently available for the endocrine therapy of breast cancer behaves as a mixed agonist/antagonist of estrogen action, thus limiting its therapeutic potential. We report the binding characteristics of a novel